Blood Diseases

Can Latin America become a global hub for innovative therapies? 🚀 Bristol Myers Squibb is shifting from country-by-country tactics to a unified regional strategy—backed by 100 active trials across 1,000+ sites, regulatory reliance pathways, and risk‑sharing models—to shorten the five‑year lag after US/EU approvals and scale launches (8 molecules, 16 indications by 2030) that could reach 1.5M patients. This approach ties clinical investment to Health Economics and market access solutions to drive sustainable, equitable impact across oncology, immunology, cardiovascular disease and beyond. Read the full interview with Constanza Losada to learn how collaboration, digital transformation and HEOR are reshaping access across LATAM. #SyenzaNews #HealthEconomics #clinicaltrials #MarketAccess #innovation

🚀 #SyenzaNews: Exciting updates from the latest PBAC outcomes! Discover new drug listings and recommendations that promise to transform elderly healthcare in Australia. From prostate cancer treatments to advanced Parkinson's disease solutions, these innovations are set to make a significant impact. 🌟 #ElderlyHealthcare #PharmaInnovation #HealthcareNews #PBAC #MedicalUpdates

🌍 Community pharmacies in Nigeria are stepping up to enhance HIV testing services! With a 90% participation rate, these pharmacies are proving to be crucial in the fight against AIDS. Discover how effective implementation strategies are making a difference. #SyenzaNews #HIVTesting #HealthcareInnovation #CommunityPharmacy #EndAIDS2030 📢 Read our latest article to learn more about the role of community pharmacies in expanding HIV testing services and how this initiative is helping to achieve global health goals.

🔍 Understanding QALYs in Healthcare Decision-Making 🔍 The recent passage of HR 485 has sparked a debate on the use of Quality-Adjusted Life Years (QALYs) in healthcare. QALYs are crucial for measuring the effectiveness of medical treatments, ensuring fair treatment for all. Learn about their importance and the potential implications of HR 485. #Healthcare #MedicalResearch #QALYs #HealthPolicy #HealthEconomics #MedicalInnovation

Namibia has reached a historic milestone by eliminating mother-to-child transmission of HIV and hepatitis B! 🌍👏 This achievement showcases the power of integrated healthcare strategies and committed political leadership. Learn more about Namibia's journey and the lessons it offers for global health. #PublicHealth #HIV #HepatitisB #HealthcareInnovation #GlobalHealth

🌍🏙️ The Fast-Track City Program is revolutionising the battle against HIV/AIDS, now with over 550 cities on board! 🏙️🌍 In Africa, cities like eThekwini and Johannesburg are at the forefront, with South Africa's PrEP initiations soaring from 170,000 to 217,000 between 2021 and 2023. 📈💡 Let's champion this initiative to achieve an AIDS-free future by 2030! 💪 #FastTrackCityProgram #EndAIDS2030 #HealthcareInnovation #GlobalHealth

🔬New insights into the cost-effectiveness of #Emicizumab treatment for non-severe Haemophilia A patients. 💡Our latest article breaks down the findings from the HAVEN 6 trial and offers a fresh perspective on value-based healthcare. 📊 #WorldHaemophiliaDay, #Healthcare #HaemophiliaCare #Pharma #ValueBasedHealthcare. Read more here. @Roche

The integration of AI into medical imaging is reshaping the future of diagnostics and patient care. With FDA-cleared AI devices making enhancements in clinical settings, we're witnessing a new era of precision and efficiency. From detecting lesions to aiding in diagnosis, AI-enabled CAD devices are enhancing clinician capabilities like never before. 🔍 Dive into our latest article to uncover the insights and innovations behind AI in medical imaging. Learn about the different types of CAD devices and how they're integrating into clinical workflows to improve patient outcomes. Let's embrace the future of healthcare together. #AIinHealthcare #MedicalImaging #InnovationInMedicine #FutureOfHealthcare Click the link to read more:

Uncover the potential of SGLT2 inhibitors in managing diabetes and associated conditions. 📚💡🔬Our latest article delves into their cost-effectiveness and future prospects. Read now to stay informed! #DiabetesTreatment #HealthcareInnovation #SGLT2Inhibitors 💊🔬

🔬 Discover the crucial role of #TPMT and #NUDT15 in #ThiopurineTherapy in our latest article. Understand why genetic testing is essential to optimise treatment, reduce risk, and save costs. Read now ➡️ #Pharmacogenetics #CostEffectiveness #PharmaMarketAccess

🔍📊 Unlocking Insights in Cancer Research: TCGA Pathology Report Corpus 🧬🔬 Discover how the TCGA pathology report corpus empowers researchers with a treasure trove of data for diverse analyses! From cancer-subtype classification to survival prediction and named entity recognition, this resource fuels cutting-edge research in oncology. With advancements like GPT-4 enhancing AI capabilities, benchmarking model performance on pathology report text becomes crucial. 🚀

🔬 South Africa is pioneering a new #HIVPrevention injection, offering two months of protection with just one shot. 👉 Discover how South Africa navigates this new treatment within budgetary constraints in its HIV budget. Learn about the strategies employed to maximise impact amidst financial pressure. Read more here:#HIVResponse #SouthAfrica #HealthcareStrategies #Healthcare